COQ7
protein-codingcoenzyme Q7, hydroxylase
Gene summary
The protein encoded by this gene is similar to a mitochondrial di-iron containing hydroxylase in Saccharomyces cerevisiae that is involved with ubiquinone biosynthesis. Mutations in the yeast gene lead to slower development and longer life span. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014754
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0018894
Submitter: ClinGen
COQ7: autosomal recessive distal hereditary motor neuropathy (dHMN) Evidence Summary: Coenzyme Q7 (COQ7) encodes a mitochondrial hydroxylase that catalyzes the penultimate step in the biosynthesis of coenzyme Q10 (CoQ10), an essential electron carrier of the mitochondrial respiratory chain required for oxidative phosphorylation and ATP production (Jacquier et al., PMID: 36454683). Pathogenic variants in COQ7 have been associated with primary CoQ10 deficiency (Freyer et al., PMID: 26084283) and distal hereditary motor neuropathy (dHMN) (Jacquier et al., PMID: 36454683; Rebelo et al., PMID: 37170631). Both primary CoQ10 deficiency and dHMN due to COQ7 biallelic variants were lumped into a single disease entity, as both phenotypes share the same autosomal recessive inheritance pattern, overlapping neurological features including motor neuropathy and upper motor neuron signs, and a common loss-of-function mechanism resulting in CoQ10 deficiency, with at least 3 shared gene variants (R54Q, R107W, I200WfsTer56). Affected individuals with dHMN and biallelic COQ7 variants present with distal motor neuropathy with pes cavus, often accompanied by upper motor neuron signs like brisk reflexes and/or Babinski sign. Evidence supporting this gene–disease relationship includes case-level data, segregation data, and experimental data from multiple independent cohorts, with multiple missense or null variants reported (Jacquier et al.; Rebelo et al.; Liu et al., PMID: 36758993; Smith et al., PMID: 37077559; Zhang et al., PMID: 37077559). Functional studies demonstrated decreased COQ7 mRNA and protein expression, impairing CoQ10 biosynthesis and mitochondrial respiration in vitro. Patient-derived iPSC motor neurons also showed reduced protein levels of COQ7 and increased levels of neurofilament light protein leakage, indicating axonal damage (Rebelo et al.). In summary, there is STRONG evidence supporting this gene-disease relationship. This classification was approved by the ClinGen Charcot-Marie-Tooth Expert Panel on the March 13 2026 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0014754
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Renal
Intervention: Biochemical
Rationale: Treatment with coenzyme Q10 has been described as possibly beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COQ7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016138.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 40 | 1 | 43 | ||
| missense | 5 | 3 | 87 | 11 | 1 | 107 |
| nonsense | 1 | 3 | 4 | |||
| start loss | 1 | 2 | 3 | |||
| frameshift | 1 | 5 | 6 | 12 | ||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 5 | |||
| Total | 8 | 11 | 102 | 51 | 2 | 174 |
Highest pathogenic variant AF is 0.000036938432
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057222.2 | 6 | MANE Select | |
| Ensembl | ENSP00000322316.5 | 6 | MANE Select | |
| RefSeq | NP_001177912.1 | 5 | Standard | |
| RefSeq | NP_001357418.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens (human)
- Ubiquinone Biosynthesis
- Metabolism
- Ubiquinol biosynthesis
- Metabolism of cofactors
Biological Process
- negative regulation of transcription by RNA polymerase II
- ubiquinone biosynthetic process
- determination of adult lifespan
- response to drug
- mitochondrial ATP synthesis coupled electron transport
Molecular Function
- protein binding
- 2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
- metal ion binding
Cellular Component
- nucleus
- mitochondrial inner membrane
- extrinsic component of mitochondrial inner membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000321998
- Coding exons
- 6
- Length
- 12497
- Individuals with no LoFs
- 125702
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 44
- Defined
- 125746
- p
- 0.000175
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.463 | 153 | 138 | 1.11 | 0.00000839 | 1391 |
| Missense (PolyPhen) | 46 | 43.882 | 1.0483 | 429 | ||
| Synonymous | -0.276 | 57 | 54.4 | 1.05 | 0.00000349 | 425 |
| Loss of Function | 0.418 | 9 | 10.5 | 0.861 | 5.12e-7 | 121 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00079 | 0.00079 | rare |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0.00021 | 0.00020 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the hydroxylation of 2-polyprenyl-3-methyl-6- methoxy-1,4-benzoquinol (DMQH2) during ubiquinone biosynthesis. Has also a structural role in the COQ enzyme complex, stabilizing other COQ polypeptides. Involved in lifespan determination in a ubiquinone-independent manner. {ECO:0000255|HAMAP-Rule:MF_03194}.;
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- LoFtool
- 0.728
- RVIS EVS
- -0.12
- RVIS percentile EVS
- 45.13
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.882
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |